Recruiting
Phase 2

The Clostridioides Difficile Trial of REC-3964

Sponsor:

Recursion Pharmaceuticals Inc.

Code:

NCT06536465

Conditions

Recurrent Clostridioides Difficile Infection

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

REC-3964

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Recursion Pharmaceuticals Inc. on 2025-03-25.